EDN1 and coronary vasospasm: 5-FU and its active metabolites can impair the normal functioning endothelium, leading to an elevated release of endothelin-1, a vasoconstrictor, and a diminished release of prostacyclin, a vasodilator causing coronary vasospasm (11–14).